ROR1 and diffuse large B-cell lymphoma: ROR1 expression showed a significant prognostic factor in patients with CLL, and several studies identified aberrant expression of ROR1 in other hematologic malignancies, diffuse large B cell lymphoma, follicular lymphoma, and marginal zone lymphoma [24].